Target intelligence / Profile preview

DENN domain-containing protein 3 (DENND3)

Target
DENND3
Molecular classification
Guanine nucleotide exchange factor (GEF), Rab GTPase activator, Other (regulator of membrane trafficking)
01

Overview

DENN domain-containing protein 3 (DENND3) is a guanine nucleotide exchange factor (GEF) that specifically activates the small GTPase Rab12, a key regulator of intracellular membrane trafficking. DENND3 controls trafficking events between recycling endosomes and lysosomes, promoting degradation of receptors such as the transferrin receptor and modulating nutrient transporter PAT4, thereby influencing autophagic flux and metabolic pathways. Phosphorylation by kinases such as ULK1/2 and at specific tyrosine residues modulates its activity, particularly during starvation-induced autophagy. DENND3 is associated with pathological conditions including certain cancers and Hirschsprung disease. At the molecular level, it functions mainly in membrane dynamics, autophagy initiation, signal transduction, and protein trafficking[1][2][3][4][5][6].

Other names
DENND3KIAA0870DENN/MADD domain containing 3
02

Mechanism of action

Activation of Rab12 by facilitating GDP-GTP exchange\nUpregulation via phosphorylation-dependent conformational changes

03

Biological functions

Regulation of Rab protein signal transductionAutophagy (starvation-induced)Endosome-to-lysosome transportProtein catabolic processVesicle-mediated transport
04

Disease associations

CancerHirschsprung diseaseHematologic cancerBone metabolism disorders (candidate gene)

Beyond the preview

Go deeper on DENN domain-containing protein 3 (DENND3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENN domain-containing protein 3 (DENND3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call